GMP - The DomaniCell Advantage

DomaniCell provides a level of cGMP banking that few banks offer. We bank in compliance with FDA's cGMP standards. While today's therapies do not require cord blood stem cells banked by cGMP, we believe future cord blood stem cell therapies currently in development will require the cord blood stem cells they use to be cGMP-compliant.

For more information on the cGMP DomaniCell Advantage that could be yours, click here.

A member of the Progenitor Cell Therapy group of companies

As a member of the Progenitor Cell Therapy group of companies, DomaniCell is uniquely positioned to leverage internal scientific, manufacturing, and clinical expertise to benefit its partners and clientele.

DomaniCell, LLC is a wholly-owned subsidiary of Progenitor Cell Therapy, LLC (www.progenitorcelltherapy.com). Founded in 1997 by medical and scientific leaders in the cell therapy field, privately-held Progenitor Cell Therapy, also known as PCT, has become the leading provider of cell therapy support services to its client companies worldwide from its state-of-the-art clean room facilities and laboratories in the United States.  Headquartered in New Jersey, PCT and its subsidiary, DomaniCell, is a profitable and stable company on solid financial footing.PCT has performed over 15,000 cell-based procedures since its operations began. An ever-increasing roster of cell therapy companies and leading stem cell transplantation programs rely on PCT.

Each parent choosing DomaniCell to collect and store their baby’s cord blood stem cells can share in the same confidence as expressed in PCT by its institutional investors and some of the world’s foremost cell therapy companies which entrust the development of their products to PCT.

DomaniCell & PCT are also in the planning stages of building a national adult stem cell banking service. 

Building Hospital Partners

In addition to providing cord blood banking services direct to parents, DomaniCell partners with hospitals to offer a turnkey cordblood banking program that assures the highest quality and ease of use to participating parents.

By partnering with leading hospitals across the country, DomaniCell provides its hospital partner programs and stem cell banking clientele with the benefits gained from having a common national infrastructure and shared protocols.

The DomaniCell partnership allows participating hospital programs to quickly translate the latest cutting-edge scientific and clinical developments into ongoing program improvements focused on ensuring the stem cells collected and stored are of the highest quality and are available for use in the latest therapeutic applications.

A PharmaStem Partner

DomaniCell is a national pioneer in the field of stem cell collection and storage, providing innovative family cord blood banking services through hospital partner programs across the country.

DomaniCell has a license from PharmaStem Therapeutics, Inc. to PharmaStem's patent portfolio for the storage and use of umbilical cord blood. The nature of DomaniCell's license is exclusive.